15-73122579-A-G
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The ENST00000261908.11(NEO1):āc.503A>Gā(p.Asn168Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000253 in 1,614,064 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
ENST00000261908.11 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEO1 | NM_002499.4 | c.503A>G | p.Asn168Ser | missense_variant | 3/29 | ENST00000261908.11 | NP_002490.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEO1 | ENST00000261908.11 | c.503A>G | p.Asn168Ser | missense_variant | 3/29 | 1 | NM_002499.4 | ENSP00000261908 | A2 | |
NEO1 | ENST00000558964.5 | c.503A>G | p.Asn168Ser | missense_variant | 3/28 | 1 | ENSP00000453200 | P4 | ||
NEO1 | ENST00000560262.5 | c.503A>G | p.Asn168Ser | missense_variant | 3/28 | 1 | ENSP00000453317 | |||
NEO1 | ENST00000339362.9 | c.503A>G | p.Asn168Ser | missense_variant | 4/30 | 5 | ENSP00000341198 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152202Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000326 AC: 82AN: 251400Hom.: 1 AF XY: 0.000361 AC XY: 49AN XY: 135864
GnomAD4 exome AF: 0.000257 AC: 376AN: 1461862Hom.: 3 Cov.: 31 AF XY: 0.000297 AC XY: 216AN XY: 727236
GnomAD4 genome AF: 0.000217 AC: 33AN: 152202Hom.: 0 Cov.: 31 AF XY: 0.000161 AC XY: 12AN XY: 74368
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at